OxySure Therapeutics issues response to FDA following portable O2 system recall
OxySure Therapeutics Inc., a medical technology solution company, has issued a response to the US Food and Drug Administration (FDA) organisation after it recalled thousands of the company’s portable oxygen (O2) devices last month.